Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma- associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

Molecular and Cellular Biology

Volumn 17, Issue 4, 1997, Pages 2312-2325

  Bischof, Daniela ^a   Pulford, Karen ^b   Mason, David Y ^b   Morris, Stephan W ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; LEUCINE ZIPPER PROTEIN; MUTANT PROTEIN; NUCLEOPHOSMIN; PHOSPHOPROTEIN; PHOSPHOTRANSFERASE;

ANAPLASTIC CARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 2; CONTROLLED STUDY; GENE FUSION; MALIGNANT TRANSFORMATION; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

ANIMALIA;

EID: 0030934862     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.4.2312     Document Type: Article

References (70)

1. Barbacid, M., and A. V. Lauver. 1981. Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo. J. Virol. 40:812-821.
2. Borer, R. A., C. F. Lehner, H. M. Eppenberger, and E. A. Nigg. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390.
3. Byrd, D. A., D. J. Sweet, N. Pante, K. N. Konstantinov, T. Guan, A. C. Saphire, P. J. Mitchell, C. S. Cooper, U. Aebi, and L. Gerace. 1994. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J. Cell Biol. 127:1515-1526.
4. Chan, P., W. Chan, B. Y. M. Yung, R. G. Cook, M. B. Aldrich, D. Ku, I. L. Goldknopf, and H. Busch. 1986. Amino acid sequence of a specific antigenic peptide of protein B23. J. Biol. Chem. 25:14335-14341.
5. Chan, P. K. 1989. Cross-linkage of nucleophosmin in tumor cells by nitrogen mustard. Cancer Res. 49:3271-3275.
6. Chan, W., Q. R. Liu, J. Borjigin, H. Busch, O. M. Rennert, L. A. Tease, and P. Chan. 1989. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033-1039.
7. Chatterjee, A., R. K. Busch, D. Jung, W. W. Zhang, and H. Busch. 1991. Purification of a group of HeLa nuclear proteins that bind to a regulatory element (-1430/-1327) of the human proliferating cell nucleolar protein P120 gene. Biochem. Biophys. Res. Commun. 180:805-812.
8. Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent. 1993. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12:1161-1167.
9. Davis, L. G., W. M. Kuehl, and J. F. Battey. 1994. Three-oligonucleotide PCR to generate chimeric (or specifically deleted) DNA molecules, p. 733-737. In L. G. Davis, W. M. Kuehl, and J. F. Battey (ed.), Basic methods in molecular biology. Appleton and Lange, Norwalk, Conn.
10. Dingwall, C., and R. A. Laskey. 1990. Nucleoplasmin: the archetypal molecular chaperone. Semin. Cell Biol. 1:11-17.
11. Dumbar, T. S., G. A. Gentry, and M. O. J. Olson. 1989. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28:9495-9501.
12. Fantl, W. J., D. E. Johnson, and L. T. Williams. 1993. Signaling by receptor tyrosine kinases. Annu. Rev. Biochem. 62:453-481.
13. Feuerstein, N. 1991. Phosphorylation of numatrin and other nuclear proteins by cdc2 containing CTD kinase cdc2/p58. J. Biol. Chem. 266:16200-16206.
14. Feuerstein, N., J. J. Mond, P. R. Kinchington, R. Hickey, M. L. Karjalainen Lindsberg, I. Hay, and W. T. Ruyechan. 1990. Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim. Biophys. Acta 1087:127-136.
15. Feuerstein, N., and P. A. Randazzo. 1991. In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp. Cell Res. 194:289-296.
16. Fonagy, A., C. Swiderski, A. M. Ostrovsky, W. E. Bolton, and J. W. Freeman. 1994. Effect of nucleolar P120 expression level on the proliferation capacity of breast cancer cells. Cancer Res. 54:1859-1864.
17. Fonagy, A., C. Swiderski, A. Wilson, W. Bolton, N. Kenyon, and J. W. Freeman. 1993. Cell cycle regulated expression of nucleolar antigen P120 in normal and transformed human fibroblasts. J. Cell. Physiol. 154:16-27.
18. Fujimoto, J., M. Shiota, T. Iwahara, N. Seki, H. Satoh, S. Mori, and T. Yamamoto. 1996. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA 93:4181-4186.
19. Fumagalli, S., N. F. Totty, J. J. Hsuan, and S. A. Courtneidge. 1994. A target for Src in mitosis. Nature 368:871-874.
20. Golub, T. R., G. F. Barker, M. Lovett, and B. G. Gilliland. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307-316.
21. Golub, T. R., A. Goga, G. F. Barker, D. E. H. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and D. G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107-4116.
22. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
23. Greco, A., C. Mariani, C. Miranda, A. Lupas, S. Pagliardini, M. Pomati, and M. A. Pierotti. 1995. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol. Cell. Biol. 15:6118-6127.
24. Grignani, F., and P. G. Pelicci. 1996. Pathogenetic role of the PML1-RARα fusion protein in acute promyelocytic leukemia. Curr. Top. Microbiol. Immunol. 211:269-278.
25. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52.
26. Herrera, J. E., R. Savkur, and M. O. Olson. 1995. The ribonuclease activity of nucleolar protein B23. Nucleic Acids Res. 23:3974-3979.
27. Inouye, C. J., and E. Seto. 1994. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J. Biol. Chem. 269:6506-6510.
28. Kadin, M. E. 1994. Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J. Clin. Oncol. 12:884-887. (Editorial.)
29. Kahn, S. M., W. Jiang, C. Borner, K. O'Driscoll, and I. B. Weinstein. 1990. Construction of defined deletion mutants by thermal cycled fusion: applications to protein kinase C. J. Methods Cell Mol. Biol. 2:27-30.
30. Lamant, L., F. Meggetto, T. Al Saati, L. Brugieres, B. de Paillerets, N. Dastugue, A. Bernheim, H. Rubie, M. J. Terrier-Lacombe, A. Robert, P. Brousset, F. Rigal, D. Schlaifer, M. Shiota, S. Mori, and G. Delsol. 1996. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87:284-291.
31. Lanzi, C., M. G. Borrello, I. Bongarzone, A. Migliazza, A. Fusco, M. Grieco, M. Santoro, R. A. Gambetta, F. Zunino, G. Della Porta, and M. A. Pierotti. 1992. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 7:2189-2194.
32. Liu, Q. R., and P. K. Chan. 1991. Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein. Eur. J. Biochem. 200:715-721.
33. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-142.
34. Lugo, T. G., A. M. Pendergast, A. J. Muller, and O. N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079-1082.
35. Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162-1164.
36. Martin-Zanca, D., S. H. Hughes, and M. Barbacid. 1986. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319:743-748.
37. Maru, Y., and O. N. Witte. 1991. The BCR gene encodes a novel serine/ threonine kinase activity within a single exon. Cell 67:459-168.
38. Mason, D. Y., C. Bastard, R. Rimokh, N. Dastugue, J. L. Huret, U. Kristoffersson, J. P. Magaud, C. Nezelof, H. Tilly, J. P. Vannier, V. J. Hemet, and R. Warnke. 1990. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 74:161-168.
39. McWhirter, J. R., D. L. Galasso, and J. Y. Wang. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587-7595.
40. Morgan, R., S. D. Smith, B. K. Hecht, V. Christy, J. D. Mellentin, R. Warnke, and M. L. Cleary. 1989. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155-2164.
41. Morris, S. W. Unpublished data.
42. Morris, S. W., and H. Hitzler. Unpublished data.
43. Morris, S. W., M. N. Kirstein, M. B. Valentine, K. G. Dittmer, D. N. Shapiro, D. L. Saltman, and A. T. Look. 1994. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263: 1281-1284.
44. Morris, S. W., C. Naeve, P. Mathew, P. L. James, M. N. Kirstein, X. Cui, and D. P. Witte. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene, in press.
45. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
46. Myers, M. G., Jr., X. J. Sun, and M. F. White. 1994. The IRS-1 signaling system. Trends Biochem. Sci. 19:289-293.
47. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
48. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
49. Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161-171.
50. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175-185.
51. Perlaky, L., B. C. Valdez, R. K. Busch, R. G. Larson, S. M. Jhiang, W. W. Zhang, M. Brattain, and H. Busch. 1992. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res. 52:428-436.
52. Peter, M., J. Nakagawa, M. Doree, J. C. Labbe, and E. A. Nigg. 1990. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60:791-801.
53. Pulford, K., L. Lamant, S. W. Morris, L. H. Butler, K. M. Wood, D. Stroud, G. Delsol, and D. Y. Mason. Detection of ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood, in press.
54. Rabbitts, T. H. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
55. Redner, R. L., E. A. Rush, S. Faas, W. A. Rudert, and S. J. Corey. 1996. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosminretinoic acid receptor fusion. Blood 87:882-886.
56. Rodrigues, G. A., and M. Park. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol. 13:6711-6722.
57. Rodrigues, G. A., and M. Park. 1994. Oncogenic activation of tyrosine kinases. Curr. Opin. Genet. Dev. 4:15-24.
58. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
59. Sawyers, C. L., and C. T. Denny. 1994. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77:171-173.
60. Schmidt-Zachmann, M. S., and W. W. Franke. 1988. cDNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli. Correspondence of the nucleoplasmin-related protein NO38 to mammalian protein B23. Chromosoma 96:417-426.
61. Seto, E., B. Lewis, and T. Shenk. 1993. Interaction between transcription factors Sp1 and YY1. Nature 365:462-164.
62. Shi, Y., E. Seto, L. S. Chang, and T. Shenk. 1991. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67:377-388.
63. Shiota, M., J. Fujimoto, T. Semba, H. Satoh, T. Yamamoto, and S. Mori. 1994. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567-1574.
64. Stokoe, D., S. G. Macdonald, K. Cadallader, M. Symons, and J. F. Hancock. 1994. Activation of raf as a result of recruitment to the plasma membrane. Science 264:1463-1467.
65. Takemura, M., N. Ohta, Y. Furuichi, T. Takahashi, S. Yoshida, M. O. Olson, and H. Umekawa. 1994. Stimulation of calf thymus DNA polymerase alpha activity by nucleolar protein B23. Biochem. Biophys. Res. Commun. 199:46-51.
66. Taylor, S. J., and D. Shalloway. 1994. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 368:867-871.
67. van der Geer, P., and T. Pawson. 1995. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20:277-280.
68. Van Etten, K. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
69. Wang, J. Y. J. 1994. Nuclear protein tyrosine kinases. Trends Biochem. Sci. 19:373-376.
70. Yoneda-Kato, N., A. T. Look, M. N. Kirstein, M. B. Valentine, S. C. Raimondi, K. J. Cohen, A. J. Carroll, and S. W. Morris. 1996. The t(3;5)(q25.1; q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene. NPM-MLF1. Oncogene 12:265-275.